๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Decrease in lymphokine-activated killer sensitivity of a human renal-cell carcinoma cell line after cytokine treatment

โœ Scribed by Masahiro Yanase; Taiji Tsukamoto; Yoshiaki Kumamoto; Kazunori Kato; Yoshiyuki Hashimoto

Publisher
Springer-Verlag
Year
1994
Tongue
English
Weight
522 KB
Volume
39
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase iii randomized trial of interleuki
Phase iii randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma
โœ Teresa Murray Law; Robert J. Motzer; Madhu Mazumdar; Kenneth W. Sell; Philip Wal ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 723 KB

Background. Treatment with interleukin-2 (IL-2) and lymphokine-activated killer cells (LAK) resulted in responses in some patients with advanced renal cell carcinoma (RCC). However, the relative therapeutic benefit of the addition of LAK to IL-2 was unknown. Methods. A randomized Phase I11 trial wa